Telo Genomics Corp.
TELO.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.56M | 243.00K | 581.60K | 510.20K | 980.70K |
| Total Receivables | 20.50K | 12.90K | 22.80K | 22.70K | 53.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 25.50K | 39.40K | 67.00K | 60.40K | 74.80K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.61M | 295.30K | 671.50K | 593.30K | 1.11M |
|
|
|||||
| Total Current Assets | 1.61M | 295.30K | 671.50K | 593.30K | 1.11M |
| Net Property, Plant & Equipment | 2.60K | 3.90K | 6.60K | 10.20K | 16.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 23.80K | 26.60K | 27.50K | 29.00K | 31.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.64M | 325.80K | 705.50K | 632.50K | 1.16M |
|
|
|||||
| Total Accounts Payable | 309.10K | 190.80K | 193.90K | 134.50K | 113.10K |
| Total Accrued Expenses | 110.50K | 107.60K | 80.50K | 55.30K | 105.70K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 419.60K | 298.40K | 274.40K | 189.80K | 218.70K |
|
|
|||||
| Total Current Liabilities | 419.60K | 298.40K | 274.40K | 189.80K | 218.70K |
| Long-Term Debt | -- | -- | -- | -- | 24.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 419.60K | 298.40K | 274.40K | 189.80K | 243.30K |
|
|
|||||
| Common Stock & APIC | 21.37M | 21.04M | 20.77M | 20.55M | 21.07M |
| Retained Earnings | -20.15M | -21.01M | -20.33M | -20.11M | -20.16M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 1.22M | 27.50K | 431.10K | 442.70K | 912.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.22M | 27.50K | 431.10K | 442.70K | 912.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.22M | 27.50K | 431.10K | 442.70K | 912.90K |
|
|
|||||
